EE9900226A - Nucleic and amino acid sequences associated with Helicobacter pylori and their vaccine compositions - Google Patents
Nucleic and amino acid sequences associated with Helicobacter pylori and their vaccine compositionsInfo
- Publication number
- EE9900226A EE9900226A EEP199900226A EE9900226A EE9900226A EE 9900226 A EE9900226 A EE 9900226A EE P199900226 A EEP199900226 A EE P199900226A EE 9900226 A EE9900226 A EE 9900226A EE 9900226 A EE9900226 A EE 9900226A
- Authority
- EE
- Estonia
- Prior art keywords
- nucleic
- amino acid
- acid sequences
- helicobacter pylori
- vaccine compositions
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75962596A | 1996-12-05 | 1996-12-05 | |
| US82374597A | 1997-03-25 | 1997-03-25 | |
| US89192897A | 1997-07-14 | 1997-07-14 | |
| PCT/US1997/022104 WO1998024475A1 (en) | 1996-12-05 | 1997-12-05 | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900226A true EE9900226A (en) | 1999-12-15 |
Family
ID=27419527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900226A EE9900226A (en) | 1996-12-05 | 1997-12-05 | Nucleic and amino acid sequences associated with Helicobacter pylori and their vaccine compositions |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0964699A4 (en) |
| JP (1) | JP2001510992A (en) |
| KR (1) | KR20000069297A (en) |
| CN (1) | CN1246799A (en) |
| AR (1) | AR010337A1 (en) |
| AU (1) | AU739641B2 (en) |
| BR (1) | BR9714133A (en) |
| CA (1) | CA2273199A1 (en) |
| EE (1) | EE9900226A (en) |
| ID (1) | ID21946A (en) |
| IL (1) | IL129746A0 (en) |
| IS (1) | IS5047A (en) |
| NO (1) | NO992158L (en) |
| NZ (1) | NZ335633A (en) |
| PL (1) | PL333943A1 (en) |
| SK (1) | SK57999A3 (en) |
| TR (1) | TR199901262T2 (en) |
| WO (1) | WO1998024475A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69932345T2 (en) * | 1998-10-26 | 2007-07-19 | Novozymes A/S | PREPARATION AND SCALING OF INTERESTING DNA BANKS IN CELLS OF FILAMENTOUS MUSHROOMS |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| US6951729B1 (en) | 1999-10-27 | 2005-10-04 | Affinium Pharmaceuticals, Inc. | High throughput screening method for biological agents affecting fatty acid biosynthesis |
| AU2000277557A1 (en) * | 2000-10-06 | 2002-04-22 | Smith Kline Beecham Corporation | Methods of agonizing and antagonizing fabk |
| US7048926B2 (en) | 2000-10-06 | 2006-05-23 | Affinium Pharmaceuticals, Inc. | Methods of agonizing and antagonizing FabK |
| WO2002066502A1 (en) * | 2001-02-21 | 2002-08-29 | Boren Thomas | Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| CN102176907A (en) * | 2008-10-08 | 2011-09-07 | 免疫解决方案有限公司 | Oral vaccines for producing mucosal immunity |
| US10828358B2 (en) | 2015-12-14 | 2020-11-10 | Technische Universität München | Helicobacter pylori vaccines |
| CN110343697A (en) * | 2019-08-05 | 2019-10-18 | 湖州三零科技股份有限公司 | A kind of plant disease fungus Total DNA extraction method |
| CN113435168B (en) * | 2021-06-10 | 2024-03-22 | 上海美吉生物医药科技有限公司 | Automatic editing method, system, terminal and medium for glue pattern |
| CN114057854B (en) * | 2021-09-30 | 2022-07-15 | 河北医科大学第四医院 | Helicobacter pylori CD4+T cell tolerance polypeptide fusion antigen and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9300139L (en) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Preparation of a new drug |
-
1997
- 1997-12-05 AU AU58954/98A patent/AU739641B2/en not_active Ceased
- 1997-12-05 AR ARP970105740A patent/AR010337A1/en not_active Application Discontinuation
- 1997-12-05 CN CN97181630A patent/CN1246799A/en active Pending
- 1997-12-05 JP JP52575898A patent/JP2001510992A/en active Pending
- 1997-12-05 KR KR1019997004955A patent/KR20000069297A/en not_active Application Discontinuation
- 1997-12-05 TR TR1999/01262T patent/TR199901262T2/en unknown
- 1997-12-05 CA CA002273199A patent/CA2273199A1/en not_active Abandoned
- 1997-12-05 EP EP97954525A patent/EP0964699A4/en not_active Withdrawn
- 1997-12-05 BR BR9714133-0A patent/BR9714133A/en not_active IP Right Cessation
- 1997-12-05 WO PCT/US1997/022104 patent/WO1998024475A1/en not_active Application Discontinuation
- 1997-12-05 NZ NZ335633A patent/NZ335633A/en unknown
- 1997-12-05 ID IDW990495A patent/ID21946A/en unknown
- 1997-12-05 SK SK579-99A patent/SK57999A3/en unknown
- 1997-12-05 IL IL12974697A patent/IL129746A0/en unknown
- 1997-12-05 PL PL97333943A patent/PL333943A1/en unknown
- 1997-12-05 EE EEP199900226A patent/EE9900226A/en unknown
-
1999
- 1999-05-04 NO NO992158A patent/NO992158L/en not_active Application Discontinuation
- 1999-05-10 IS IS5047A patent/IS5047A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO992158L (en) | 1999-07-05 |
| SK57999A3 (en) | 2000-05-16 |
| NZ335633A (en) | 2000-10-27 |
| EP0964699A1 (en) | 1999-12-22 |
| AU5895498A (en) | 1998-06-29 |
| BR9714133A (en) | 2000-02-29 |
| NO992158D0 (en) | 1999-05-04 |
| IL129746A0 (en) | 2000-02-29 |
| KR20000069297A (en) | 2000-11-25 |
| IS5047A (en) | 1999-05-10 |
| ID21946A (en) | 1999-08-12 |
| JP2001510992A (en) | 2001-08-07 |
| AU739641B2 (en) | 2001-10-18 |
| CA2273199A1 (en) | 1998-06-11 |
| PL333943A1 (en) | 2000-01-31 |
| CN1246799A (en) | 2000-03-08 |
| TR199901262T2 (en) | 1999-08-23 |
| AR010337A1 (en) | 2000-06-07 |
| WO1998024475A1 (en) | 1998-06-11 |
| EP0964699A4 (en) | 2005-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9900176A (en) | Nucleic and amino acid sequences associated with Helicobacter pylori and their vaccine compositions | |
| IL195649A0 (en) | Compositions comprising anti-??v??3 recombinant human antibodies and nucleic acids encoding the same | |
| HUP9901546A3 (en) | Helicobacter pylori antigens and vaccine compositions | |
| EE9900226A (en) | Nucleic and amino acid sequences associated with Helicobacter pylori and their vaccine compositions | |
| EE9800334A (en) | Nucleic and amino acid sequences associated with Helicobacter pylor and vaccine compositions derived therefrom | |
| ID17860A (en) | VACCINE COMPOSITION | |
| DE59711379D1 (en) | ORAL APPLICABLE FORMULATIONS OF CHINOLONIC OR NAPHTHYRIDONE CARBONIC ACIDS | |
| EE200200312A (en) | New Helicobacter pylori related substances and their use | |
| DE69720335D1 (en) | Recombinant fructosyl amino acid oxidase | |
| ID24500A (en) | METHODS AND COMPOSITIONS FOR DELIVERING AND MARKING INTERFERON-ALPHA NUCLEIC ACIDS | |
| EP1080225A4 (en) | Compositions and methods for the pulmonary delivery of nucleic acids | |
| DE69821053D1 (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl group-containing polytriazines | |
| HUP0000280A3 (en) | Canine ob protein compositions and methods | |
| IL130291A0 (en) | Compositions and methods for administering pneumococcal DNA | |
| ZA9710971B (en) | Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof. | |
| ZA972715B (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof. | |
| ZA979672B (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof | |
| DE69830156D1 (en) | COMPOSITIONS FOR IMMUNE IMPROVEMENT OF VACCINES | |
| HUP9903843A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| HUP0000521A3 (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| EE9700373A (en) | Nucleic acid and amino acid sequences associated with Helicobacter pylori for diagnosis and treatment | |
| RU99111594A (en) | HELICOBACTER PYLORI NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS | |
| RU99114027A (en) | HELICOBACTER PYLORY NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS | |
| ITMI941320A0 (en) | MARKING-DENATURING COMPOSITION PARTICULARLY SUITABLE FOR MARKING AND DENATURING FUELS | |
| EP1071325A4 (en) | Compositions and methods for antigen-specific vaccination |